Tiragolumab Biosimilar（Anti-TIGIT Reference Antibody） Datasheet DC Chemicals
Description Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab (HY-P9904), may be effective against multiple solid malignancies-most notably non-small cell lung cancer (NSCLC).
Cat.No A543
Name Tiragolumab Biosimilar（Anti-TIGIT Reference Antibody）

Chemical Properties

CAS 1918185-84-8
Synonyms RO 7092284;RG 6058;MTIG 7192A;Tiragolumab;Research Grade Tiragolumab(DHH72401);Tiragolumab (anti-TIGIT);RO 7092284|||RG6058-10|||MTIG-7192A|||RG6058-11|||RG-6058
pH value Corresponds to reference standard: PASS
Non-reduced CE-SDS >95%
SEC-HPLC >95%
Isoelectric Point Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality Corresponds to reference standard: PASS
Peptide mapping Corresponds to reference standard: PASS
N-terminal sequence Corresponds to reference standard: PASS

References

Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com